SLP Simulations Plus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SLP

Price (delayed)

$18.34

Market cap

$370.92M

P/E Ratio

45.85

Dividend/share

N/A

EPS

$0.4

Enterprise value

$336.09M

?
Relative Growth: Rel. Growth: 61
Relative Strength: Rel. Strength: 68
Relative Valuation: Rel. Valuation: 51
Relative Profitability: Rel. Profitability: 87

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and ...

Highlights
The net income has soared by 113% since the previous quarter and by 113% year-on-year
The company's EPS has surged by 113% QoQ and by 113% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.simulations-plus.com
Peers: SMSI

Key stats

What are the main financial stats of SLP

SLP stock price

How has the Simulations Plus stock price performed over time
Intraday
0.05%
1 week
0.6%
1 month
0.94%
1 year
39.79%
YTD
0.6%
QTD
0.16%

Financial performance

How have Simulations Plus's revenue and profit performed over time
Revenue
$82.06M
Gross profit
$52.01M
Operating income
$11.5M
Net income
$8.11M
Gross margin
63.4%
Net margin
9.9%
The operating margin has surged by 117% since the previous quarter and by 116% year-on-year
The operating income has surged by 117% since the previous quarter and by 116% year-on-year
The net income has soared by 113% since the previous quarter and by 113% year-on-year
The net margin has soared by 113% from the previous quarter and by 113% YoY

Price vs fundamentals

How does SLP's price correlate with its fundamentals

Growth

What is Simulations Plus's growth rate over time

Valuation

What is Simulations Plus stock price valuation
SLP P/E details
P/E
45.85
P/B
2.67
P/S
4.52
EV/EBIT
26.78
EV/EBITDA
18.5
EV/Sales
4.1
The company's EPS has surged by 113% QoQ and by 113% YoY
SLP's price to earnings (P/E) is 42% lower than its 5-year quarterly average of 79.5
The price to book (P/B) is 39% lower than the 5-year quarterly average of 4.4 but 16% higher than the last 4 quarters average of 2.3
SLP's equity is up by 12% year-on-year and by 3.9% since the previous quarter
The price to sales (P/S) is 63% less than the 5-year quarterly average of 12.3 but 19% more than the last 4 quarters average of 3.8
SLP's revenue is up by 2.1% YoY

Efficiency

How efficient is Simulations Plus business performance
The company's return on sales has surged by 119% QoQ and by 118% YoY
Simulations Plus's return on invested capital has surged by 118% QoQ and by 116% YoY
SLP's ROE has soared by 117% YoY and by 113% QoQ
The company's return on assets has surged by 116% YoY and by 113% QoQ

Dividends

What is SLP's dividend history
Dividend details
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Simulations Plus financials performed over time
The total liabilities is up by 32% year-on-year and by 10% since the previous quarter
The quick ratio has grown by 16% YoY
The debt is 100% less than the equity
The debt to equity has dropped by 100% year-on-year
The debt has contracted by 32% YoY and by 4.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.